12:00 AM
 | 
Nov 23, 2009
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Peregrine preclinical data

A single dose of bavituximab increased survival in hamsters infected with lethal doses of viruses from two different families that cause viral hemorrhagic fever. In vitro, bavituximab and PGN635 bound to representative viruses of major VHF virus...

Read the full 161 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >